Skip to main content

Research Repository

Advanced Search

Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase

Star, Kristina; Edwards, I. Ralph; Choonara, Imti

Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase Thumbnail


Authors

Kristina Star

I. Ralph Edwards

Imti Choonara



Abstract

Introduction

Valproic acid is an effective first line drug for the treatment of epilepsy. Hepatotoxicity is a rare and potentially fatal adverse reaction for this medicine.
Objective

Firstly to characterise valproic acid reports on children with fatal outcome and secondly to determine reporting over time of hepatotoxicity with fatal outcome.
Methods

Individual case safety reports (ICSRs) for children ?17 years with valproic acid and fatal outcome were retrieved from the WHO Global ICSR database, VigiBase, in June 2013. Reports were classified into hepatotoxic reactions or other reactions. Shrinkage observed-to-expected ratios were used to explore the relative reporting trend over time and for patient age. The frequency of polytherapy, i.e. reports with more than one antiepileptic medicine, was investigated.
Results

There have been 268 ICSRs with valproic acid and fatal outcome in children, reported from 25 countries since 1977. A total of 156 fatalities were reported with hepatotoxicity, which has been continuously and disproportionally reported over time. There were 31 fatalities with pancreatitis. Other frequently reported events were coma/encephalopathy, seizures, respiratory disorders and coagulopathy. Hepatotoxicity was disproportionally and most commonly reported in children aged 6 years and under (104/156 reports) but affected children of all ages. Polytherapy was significantly more frequently reported for valproic acid with fatal outcome (58%) compared with non-fatal outcome (34%).
Conclusion

Hepatotoxicity remains a considerable problem. The risk appears to be greatest in young children (6 years and below) but can occur at any age. Polytherapy is commonly reported and seems to be a risk factor for hepatotoxicity, pancreatitis and other serious adverse drug reactions with valproic acid.

Citation

Star, K., Edwards, I. R., & Choonara, I. (2014). Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase. PLoS ONE, 9(10), Article e108970. https://doi.org/10.1371/journal.pone.0108970

Journal Article Type Article
Acceptance Date Sep 2, 2014
Publication Date Oct 10, 2014
Deposit Date Sep 27, 2016
Publicly Available Date Sep 27, 2016
Journal PLoS ONE
Electronic ISSN 1932-6203
Publisher Public Library of Science
Peer Reviewed Peer Reviewed
Volume 9
Issue 10
Article Number e108970
DOI https://doi.org/10.1371/journal.pone.0108970
Public URL https://nottingham-repository.worktribe.com/output/738428
Publisher URL http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108970

Files





Downloadable Citations